Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem

The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver treatments and cures for patients.

FUELING COMPETITION AND INVESTMENT

M&A drives competition and investment across America's life sciences industry.

FACILITATING INNOVATION

Life sciences companies of all sizes engage in M&A to connect innovations with the resources needed to bring them to market.

DRIVING AMERICAN GROWTH, LEADERSHIP

M&A plays a critical role within America’s world-class life sciences industry.

U.S. biopharmaceutical companies headquartered in the U.S.

novel drugs that undergo M&A are 3.2x more likely to launch

of biopharmaceutical companies operate without a profit

PARTNERS

ABOUT US

PULSE is a national coalition raising awareness about the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. M&A enables life sciences companies of all sizes to bring together resources, investment and expertise needed to develop and deliver new treatments and cures. PULSE members represent researchers, manufacturers and leaders of life sciences companies of all sizes that make up a diverse, vibrant life sciences industry across America.

LATEST NEWS

ICYMI: ITIF Report Underscores the Importance of Balanced Antitrust Enforcement

A recent report from the Information Technology and Innovation Foundation (ITIF), “Antitrust Undone: How Competition Enforcers Are Undermining Competition,” highlights the risks of unnecessarily aggressive antitrust enforcement in innovative industries. The report cautions that such policies could, “adversely impact U.S. global competitiveness and innovative dynamism.”

read more